Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
TFFP | US
0.01
0.49%
Healthcare
Biotechnology
30/06/2024
18/10/2024
2.07
2.08
2.16
2.04
TFF Pharmaceuticals Inc. a clinical stage biopharmaceutical company focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voriconazole Inhalation Powder which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products such as Augmenta monoclonal antibodies for the treatment of COVID-19 therapeutics; TFF Niclosamide which is completed Phase 1 clinical trials for the treatment of COVID-19 disease; and other vaccines. TFF Pharmaceuticals Inc. has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks Inc. to develop Augmenta monoclonal antibodies; a licensing and collaboration agreement with UNION therapeutics A/S; and a collaborative research and development agreement with the National Institute of Environmental Health Sciences to develop dry powder formulations of hyaluronan to prevent and treat respiratory diseases. The company was incorporated in 2018 and is headquartered in Fort Worth Texas.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
119.1%1 month
113.4%3 months
123.7%6 months
113.8%-
-
1.22
0.01
0.01
-0.50
6.11
-
-19.01M
7.17M
7.17M
-
-609.42
-
95.10
-213.51
3.20
3.84
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.05
Range1M
1.06
Range3M
1.75
Rel. volume
0.37
Price X volume
27.04K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Alzamend Neuro Inc. Common Stock | ALZN | Biotechnology | 1.675 | 7.50M | 2.13% | n/a | 0.00% |
Pulmatrix Inc | PULM | Biotechnology | 2.0204 | 7.38M | -0.47% | n/a | 0.18% |
Moleculin Biotech Inc | MBRX | Biotechnology | 2.585 | 7.35M | 9.53% | n/a | 3.00% |
Purple Biotech Ltd | PPBT | Biotechnology | 4.37 | 6.84M | 4.55% | n/a | 0.89% |
Aptose Biosciences Inc | APTO | Biotechnology | 0.3643 | 6.60M | 1.19% | n/a | -37.59% |
Adial Pharmaceuticals Inc | ADIL | Biotechnology | 1.01 | 6.47M | 4.11% | n/a | 0.00% |
CDIO | CDIO | Biotechnology | 0.2109 | 6.45M | -0.19% | n/a | 28.31% |
Portage Biotech Inc | PRTG | Biotechnology | 6.13 | 6.43M | -8.64% | 0.25 | 1.47% |
Hoth Therapeutics Inc | HOTH | Biotechnology | 0.9285 | 6.41M | 3.17% | n/a | 0.44% |
Cyclerion Therapeutics Inc | CYCN | Biotechnology | 2.5 | 6.29M | 4.17% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 0.538 | 7.80M | -6.65% | 0.03 | 16.03% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.2201 | 3.95M | 4.26% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.76M | 1.92% | n/a | 17.32% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.01 | 897.66K | -12.28% | n/a | -37.05% |
Winnebago Industries Inc | WGO | Recreational Vehicles | 60.38 | 0 | 0.37% | 22.53 | 56.33% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.92 | 0 | -8.84% | n/a | 0.00% |
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4801 | 0 | -10.26% | n/a | 19.98% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.045 | 0 | -2.34% | n/a | 268.43% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 14.82 | 0 | 1.93% | 9.09 | 39.79% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -0.50 | 0.53 | Cheaper |
Ent. to Revenue | 6.11 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 1.22 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 123.75 | 72.80 | Riskier |
Debt to Equity | 0.01 | -1.23 | Expensive |
Debt to Assets | 0.01 | 0.25 | Cheaper |
Market Cap | 7.17M | 3.66B | Emerging |